Part-Time

Anesthesia Technician

Posted on 5/9/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$18.56 - $27.58/hr

Dorchester, Boston, MA, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • High School Diploma or Equivalent required
  • 6 months Hospital experience required
  • Experience in lieu of degree is not accepted
Responsibilities
  • Collaborates in the perioperative anesthesia care of patients to ensure safety and efficiency of care as observed by the members of the anesthesia team, and reports to the Nurse Manager of the Operating Room and the Chief of Anesthesia.
  • Participates in the transfer of patients from stretcher/bed.
  • Attaches vital signs and related monitoring devices to the patient.
  • Collaborates with the Surgical Team in positioning of patients for special procedures (spinal, epidural, sitting, prone).
  • Participates in the intubation procedure under the direction supervision of the anesthetist/anesthesiologist by preparing and holding equipment and applying cricoid pressure to the trachea.
  • Collaborates in the safe, efficient transfer of the patient from the operating room to the PACU by having transfer oxygen and ambu bag available immediately post operatively.
  • Performs related duties in a prompt and courteous manner, such as transporting blood samples to respiratory for blood gases.
  • Maintains appropriate supply of anesthesia equipment and pharmaceutical supplies in all locations where anesthesia and related procedures are administered in the hospital to facilitate prompt anesthesia care for the patient. These activities are monitored by the anesthesia staff and reported to the Nurse Manager of the Operating Room and the Chief of Anesthesia.
  • Coordinates requests from the anesthesia team by collecting items needed during each surgical procedure.
  • Maintains par levels of gas tanks for the anesthesia units (machines).
  • Maintains anesthesia equipment/monitoring units in working condition communicating with the biomedical department and/or equipment service representatives to insure availability of equipment.
  • Executes equipment repairs within 24 hours to ensure patient safety and continuance of planned schedule of surgical procedures.
  • Monitors a log of daily anesthesia equipment safety checks, performed by anesthesia technician, and documented appropriately, to comply with safety requirements established by the hospital, accreditation requisites and regulatory agencies.
  • Assists the Nurse Manager by completing purchase requisitions for needed items when par levels are affected.
  • Maintains all equipment and instrumentation in clean organized condition in accordance to the hospital infection management policy.
  • Maintains cleanliness of all anesthesia carts and machines.
  • Maintains appropriately, special instruments and equipment, i.e. fiberoptic bronchoscope, endtidal, CO2 monitors, humidifiers, etc.
  • Operates STERIS machine and sterilizers according to operational standards.
  • Participates in the special cleaning and/or removal and terminal sterilization of equipment exposed to diagnosed contagious diseases. Participates in quality assurance activities for the operating room and the Department of Anesthesia upon request.
  • Collects data as required by the quality assurance criteria determined by the Chief of Anesthesia and/or Nurse Manager.
Desired Qualifications
  • Previous Anesthesia Tech Experience preferred

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.7B

Headquarters

Cambridge, Massachusetts

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • 20 exits since inception including eight IPOs and twelve acquisitions demonstrate proven value creation.
  • Strategic focus on digital health and AI positions firm for high-growth healthcare innovation trends.
  • Integrated academic-clinical ecosystem provides technical validation and talent pipeline advantages.

What critics are saying

  • Escalating nurse strikes at Mass General Brigham disrupt operations and damage institutional reputation.
  • Portfolio company failures like Instride erode LP confidence and future fundraising capacity.
  • Competing VCs from non-MGB institutions capture superior deal flow, limiting proprietary advantage.

What makes Mass General Brigham unique

  • Proprietary deal flow from Mass General Brigham's research community and Harvard Medical School faculty.
  • Dedicated AI and Digital Innovation Fund targeting venture-stage healthcare companies since 2020.
  • Active company building support through Amplify program beyond capital provision.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mass General Brigham who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.

CityBiz
Oct 7th, 2025
Affinia Therapeutics Secures $40M Series C

Avidity Partners has participated in a $40 million Series C funding round for Affinia Therapeutics, a company specializing in adeno-associated virus (AAV) gene therapies.

Business Wire
Oct 4th, 2025
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubs...

PR Newswire
May 7th, 2025
Carta Healthcare Secures $18.25M Series B1 Funding

Carta Healthcare has secured $18 million in Series B1 funding to enhance its AI-powered clinical data abstraction and analytics. The investment, led by UPMC Enterprises with participation from several health ventures, will support Carta's growth in the life sciences market. The funding follows Carta's acquisition of Realyze Intelligence and aims to expand its customer base and improve healthcare data management. CEO Brent Dover highlighted the investment's role in scaling operations and product deployment.

Fierce Biotech
Feb 12th, 2025
Sanofi-backed Abcuro raises $200M series C to fund pivotal trial of KLRG1 antibody

Sanofi-backed Abcuro has secured